Company intelligence / Profile preview

Cassella

Frankfurt am Main, Hesse, Germanycasella.com ↗

Ownership: Private
Employees: ~2500
Development stage: Other

Overview

Cassella was a major German chemical and pharmaceutical company founded in 1798. Initially focused on dyes—becoming the world’s largest producer by the early 20th century—it shifted to pharmaceuticals and cosmetics after World War II. It played a significant role in early chemotherapy research through collaboration with Paul Ehrlich. The company was acquired over time by Hoechst and ultimately became part of Sanofi’s corporate lineage.

Modalities: Small molecule
Industry: Pharma

Drug pipeline

1 asset

Carbocromen

Discontinued

Partnerships

Historical: Collaborated with Paul Ehrlich for chemotherapy research.Later: Part of IG Farben trust from 1925–1945.Postwar: Shareholders included BASF, Bayer, Hoechst until full control by Hoechst in 1970.

Beyond the preview

Go deeper on Cassella.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cassella.

Explore the full profile